{"entity":{"type":"insider","cik":"0002043558","url":"/insider/0002043558","json_url":"/insider/0002043558.json","name":"Rieger Jayson","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2024-11-26","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Rieger Jayson","source":"filing","n_filings":3,"first_seen":"2024-11-26","last_seen":"2026-08-18"}],"transactions":[{"id":9297098,"accession":"0002043558-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002043558-26-000005","line_url":"/filing/0002043558-26-000005#line-2","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0002043558","owner_name":"Rieger Jayson","owner_display_name":"Rieger Jayson","owner_url":"/insider/0002043558","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":24550.0,"total_display":"24,550.00","total_whole":"24,550","shares_owned_after":207593.0,"shares_owned_after_display":"207,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-18","scope":"insider"},{"id":9297099,"accession":"0002043558-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002043558-26-000005","line_url":"/filing/0002043558-26-000005#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0002043558","owner_name":"Rieger Jayson","owner_display_name":"Rieger Jayson","owner_url":"/insider/0002043558","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.06,"price_display":"5.06","price_state":"stated","total_value":101200.0,"total_display":"101,200.00","total_whole":"101,200","shares_owned_after":202593.0,"shares_owned_after_display":"202,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-14","filed_date":"2026-08-18","scope":"insider"},{"id":4936266,"accession":"0002043558-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002043558-25-000003","line_url":"/filing/0002043558-25-000003#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0002043558","owner_name":"Rieger Jayson","owner_display_name":"Rieger Jayson","owner_url":"/insider/0002043558","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":94311.0,"shares_display":"94,311","price_per_share":4.2425,"price_display":"4.24","price_state":"stated","total_value":400114.4175,"total_display":"400,114.42","total_whole":"400,114","shares_owned_after":182593.0,"shares_owned_after_display":"182,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-25","scope":"insider"},{"id":3238086,"accession":"0001415889-24-027711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-027711","line_url":"/filing/0001415889-24-027711#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0002043558","owner_name":"Rieger Jayson","owner_display_name":"Rieger Jayson","owner_url":"/insider/0002043558","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":280898.0,"shares_display":"280,898","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":832826.0,"shares_owned_after_display":"832,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001660334","name":"Verrica Pharmaceuticals Inc.","url":"/issuer/0001660334","role":"Director, Officer (CEO and President)","n_filings":3,"first_seen":"2024-11-26","last_seen":"2026-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002043558","retrieved_at":"2026-08-26T08:02:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}